Dopamine transporter (DAT) internalization is a mechanism underlying the decreased dopamine reuptake caused by addictive drugs like methamphetamine (METH). We found that Piccolo, a presynaptic scaffolding protein, was overexpressed in the nucleus accumbens (NAc) of the mice repeatedly administrated with METH. Piccolo downexpression by antisense technique augmented METH-induced behavioral sensitization, conditioned reward and synaptic dopamine accumulation in NAc. Expression of Piccolo C 2 A domain attenuated METH-induced inhibition of dopamine uptake in PC12 cells expressing human DAT. Consistent with this, it slowed down the accelerated DAT internalization induced by METH, thus maintaining the presentation of plasmalemmal DAT. In immunostaining and structural modeling Piccolo C 2 A domain displays an unusual feature of sequestering membrane phosphatidylinositol 4,5-bisphosphate, which may underlie its role in modulating DAT internalization. Together, our results indicate that Piccolo upregulation induced by METH represents a homeostatic response in the NAc to excessive dopaminergic transmission. Piccolo C 2 A domain may act as a cytoskeletal regulator for plasmalemmal DAT internalization, which may underlie its contributions in behavioral plasticity.
Introduction
Dopamine transporter (DAT), a member of the Na þ /Cl À -dependent transporters in the dopaminergic neurons, is critical for terminating dopamine (DA) neurotransmission and contributes to the abuse potential of psychostimulants. The stimulating and reinforcing effects of drugs result from enhanced synaptic DA accumulation in specific brain areas like nucleus accumbens (NAc). Cocaine and methamphetamine (METH; or its analogue amphetamine) elevate extracellular DA by inhibiting DA reuptake through DAT and, in the case of METH, also by promoting reverse transport of nonvesicular DA, reducing plasma membrane DAT through internalization, and displacing DA from synaptic vesicle (SV) to the cytoplasm. 1, 2 Membrane trafficking of DAT is closely associated with DA homeostasis and synaptic plasticity, and increasing evidences have showed that METH-like drugs are able to modulate this dynamic process. 3 The internalization of plasmalemmal DAT is a clathrinmediated process, 4, 5 and internalized DAT can be sorted to endosomal compartments where they may be recycled to cell surface and/or lysosome for degradation. 6 Inhibition of endocytic machinery assembly can attenuate amphetamine-or phorbol ester-mediated DAT internalization, 7 whereas expression of endosomal proteins like Rab5 in endosomal vesicles promotes amphetamine-induced intracellular DAT accumulation. 8 These findings strongly suggest that manipulation of endocytic components could be an important manner for regulating DAT internalization.
Piccolo, a component of the presynaptic cytoskeletal matrix, is assembled ultrastructurally as an electron-dense region of filaments at the active zone (AZ). It is proposed to play a scaffolding role in regulating AZ assembly, 9 actin cytoskeleton and SV trafficking. 10, 11 Piccolo contains multiple subdomains including PDZ domain and Ca 2 þ /phospholipid binding (C 2 A and C 2 B) domains, each of which exhibits distinctive features. 10, 12 PDZ domain may interact with other presynaptic molecules involving molecule anchoring and assembly at AZ.
13 C 2 A domain shows an unusual ability to sense intracellular changes of Ca 2 þ levels and then trigger the association with membrane phospholipids (PIs) via electrostatic interaction.
14 Notably, it interacts with phosphatidylinositol 4,5-bisphosphate (PIP 2 ), 15 a critical molecule for actin dynamics and endocytosis. It is well established that PIP 2 coordinates membrane fusion with actin filament to promote membrane movement, and recruits accessory adaptors for clathrin-coated pits. 16 Therefore, modulation of plasmalemmal PIP 2 may affect PIP 2 -dependent biological processes like membrane trafficking and endocytosis.
In this study we find that Piccolo servers as a negative presynaptic modulator for behavioral hypersensitivity and blunts excessive dopaminergic synaptic plasticity by regulating plasmalemmal DAT internalization. Moreover, Piccolo C 2 A domain may contribute to such distinct effects by targeting membrane PIP 2 .
Materials and methods

Material
A pCMV-hDAT expression plasmid was kindly provided by Dr Marc Caron (Duke University Medical Center). The expression plasmids of pCMV-HA-Piccolo-PDZ (amino acid 3900-4244), pCMV-Myc-Piccolo-C 2 A (amino acid 4704-5610) and pGEX4T-GST-p13192 (amino acid 4364-4755; named p13192) were constructed as previously described. 17 The following antibodies were used: hDAT and tyrosine hydroxylase (TH; Chemicon International Inc., Billerica, MA); hemagglutinin epitope (HA) and c-Myc (Cell Signaling, Billerica, MA); GST (Amersham Biosciences, Uppsala, Sweden); Piccolo and Rim 2 (Synaptic Systems, Albany, OR); PIP 2 (Assay Designs, Ann Arbor, MI, USA); syntaxin 1A (Santa Cruz Biotechnology, Santa Cruz, CA); synaptophysin (Sigma-Aldrich, St Louis, MO). The following reagents were used: botulinum neurotoxin (Bont)/C1 and Bont/B (Wako Pure Chemical Industries Ltd, Osaka, Japan); sulfo-NHS-biotin and immobilized streptavidin (Pierce, Rockford, IL).
RT-PCR and real-time RT-PCR
Isolation of total RNA from the NAc of mice was performed using RNeasy Mini Kit (QIAGEN, Hilden, Germany). The mRNA productions from nine target cDNA sequences of Piccolo were assayed by reverse transcription (RT)-PCR, followed by electrophoresis. The forward and reverse primers for the nine sequences were shown in Supplementary Table 1 . Piccolo mRNA levels in brain NAc were validated by quantitative real-time RT-PCR using an iCycler System (Bio-Rad, Hercules, CA). Briefly, isolation of total RNA was performed using RNeasy Mini Kit (QIAGEN). For reverse transcription, 1 mg RNA was converted into a cDNA by a standard 20 ml reverse transcriptase reaction using oligo (dT) primers (Invitrogen, Hercules, CA) and Superscript II RT (Bio-Rad Laboratories, Hercules, CA, USA). Total cDNA (1 ml) was amplified in a 25 ml reaction mixture using 0.1 mM each of forward and reverse primers and Platinum Quantitative PCR SuperMix-UDG (Invitrogen). The primer and dye probes were designed by Nippon Gene Co. Ltd (Tokyo, Japan) using Primer Express software. The forward primer was 5 0 -GGATAGCGCACAAGGTTTTCC-3
0
(base pair 4180-4200) with reverse being 5 0 -TTCAACCGAAT CATAGGATGCTC-3 0 (base pair 4257-4279), and the dye probe was 5 0 -CACAAAGAGAATCCTGAGCTGG TCGATGA-3 0 (base pair 4192-4220). Ribosomal mRNA was used and determined as control for RNA integrity with TaqMan ribosomal RNA control reagents.
Antisense
An antisense oligodeoxynucleotide (AS; 5
0 -CTCTGCC AAAACTTC-3 0 ) and a scramble oligodeoxynucleotide (SC; 5 0 -AACGTAGTCACGTAG-3 0 ) were synthesized by Nippon Gene Co. Ltd. C57BL/6 mice were infused intracerebroventricularly with AS or SC (1 ml h À1 , 10 nmol ml À1 ), made in regular artificial cerebrospinal fluid (CSF) or CSF alone, using an implanted Alzet minipump (AP À0.5 mm, ML þ 1.0 mm from bregma, DV À2.0 mm from the skull).
Locomotor activity and CPP Test
Locomotor activity was measured using an infrared detector (Neuroscience, Tokyo, Japan) as our previous report. 18 The mice were injected with METH (1 mg kg À1 , s.c.) daily for 5 days (day 1-5), followed by locomotor activity measurement at days 1, 3 and 5. Conditioned place-preference (CPP) test was carried out according to the methods as described before but with modification in conditioning. 19 Briefly, a mouse was allowed to move freely between transparent and black boxes for 20 min once per day for 3 days (from day 2 to day 0) in the preconditioning. In the mornings from days 1 to 3, the mouse was treated with METH (1 mg kg À1 , s.c.) and put in nonpreferred box for 20 min. After an interval of 12 h the mouse was treated with saline and put in the side opposite to the METH-conditioning box for 20 min. On day 4, the post-conditioning test was performed without drug treatment, and place-conditioning behavior was expressed as post-value minus pre-value. Microdialysis C57BL/6 mice were anesthetized before a guide cannula was implanted in the NAc (AP þ 1.7 mm, ML À0.8 mm from bregma, DV À4.0 mm from the skull). 19 Meanwhile, a mini osmotic pump filled with AS, SC (10 nmol ml À1 ) or CSF was implanted intracerebroventricularly as described above. Equal numbers of animals were assigned to METH and saline pretreatment groups. Dialysis probes were inserted to the guide cannula the night prior to the experiment. Microdialysis samples were collected every 10 min (2.0 ml min
À1
). The DA output was presented as Nonspecific uptake was defined in the presence of 10 mM GBR12909 (Sigma).
Cell-surface biotinylation and internalization assays Biotinylation internalization assays were performed as described previously. 6 Structural models Molecule models of Piccolo C 2 A domain were generated using the amino-acid sequence data from Protein Data Bank (Gi:42543545). The C 2 A domain models were energy minimized using Molecular Operating Environment (MOE) software (Chemical Computing Group, Montreal, Canada) to fix any mismatches between the various structural segments. All calculations used an MMFF94x force field and a cutoff distance of 9.5 Å for nonbinding interactions. ASEDock of the MOE program was used for phospholipids and/or Ca 2 þ ions docking stimulation. DSviewer Lite software (Accelry Inc., San Diego, USA) was used for modeling of the electrostatic surface.
Statistics
All data were expressed as means ± s.e.m. Statistical significance was determined by a one-way ANOVA, followed by the Bonferroni-Dunn test for multigroup comparisons. Differences were considered significant when P < 0.05.
Results
Overexpression of Piccolo in the NAc of METH-treated mice The reasons for pursuing Piccolo for intensive investigation arose from our preliminary findings in PCR-select cDNA subtraction strategy (Clontech Laboratories, Palo Alto, CA, USA) for detecting the affected genes in the NAc by METH. The C57BL/6J mice were daily administrated with METH (2 mg kg À1 , s.c.) for 5 days, and Piccolo mRNA production in the NAc was found to increase by 240% in comparison to that of saline-treated mice ( Figure 1a ). Although little is known about the function of Piccolo in druginduced behavioral sensitization, its subcellular localization, molecular functions and interacting partners led us to presume that Piccolo overexpression elicited by METH could be involved in DA signaling strength and presynaptic plasticity.
We performed a series of experiments to validate the results from PCR-select cDNA subtraction. After the mice were daily administrated with METH (1 mg kg Figure 1c , the levels of Piccolo mRNA in the frontal cortex, striatal or hippocampus were not affected by either single or repeated METH administration. Remarkably, Piccolo mRNA level in the NAc was increased following repeated METH administration (F (2,15) = 5.58; P < 0.05), whereas it was not altered by single METH injection. We then examined Piccolo expression in the NAc using western blotting. Consistently, Piccolo protein level in NAc was elevated apparently after repeated METH administration (t (1, 8) = 7.35; P < 0.01; Figure 1d ). Immunostaining also revealed a strengthened Piccolo immunoreactivity in NAc of the mice treated with repeated METH (Figure 1e ). Taken together, our data suggest a selective increase of Piccolo expression in NAc of behaviorally sensitized mice induced by repeated METH dosing, rather than a global increase of the brain. Because NAc is a brain area closely associated with drug dependence, we presumed that Piccolo overexpression may be involved in dopaminergic plasticity in neural circuits, which is critical for reward.
Piccolo modulates behavioral plasticity and synaptic DA concentration in NAc To correlate Piccolo expression with the behavioral and neurochemical phenotype to METH, we utilized an AS strategy, which has been widely used to manipulate gene expressions in the brain via intracerebroventricular infusion. 21 The designed AS, which directs against nucleotides 2452-2466, has been demonstrated to downregulate successfully the expression of Piccolo in previous studies. 17 Additionally, a SC was used as a control.
The mice were infused continuously with AS, SC or CSF using implanted osmotic minipumps for 3 days before daily saline or METH administration (1 mg kg À1 , s.c.) for 5 days. Such infusion was sustained till the end of each behavioral test. Locomotor activities of mice were measured at days 1, 3 and 5 immediately after drug injection (Figure 2a ). There was no difference among Piccolo AS-, SCor CSF-treated mice in baseline locomotor activity throughout a 30 min habituation period (data not shown) or in response to saline (Figure 2b ). Repeated METH administration caused a progressive hyperlocomotion in mice, and interestingly, AS-pretreated mice developed a greater hyperlocomotor activity than those treated with SC or CSF after METH administration for 3 days (F (2,15) = 5.47; P < 0.05; Figure 2c ). Furthermore, such enhanced hyperlocomotor activity was sustained till day 5 despite that the difference was not significant compared with that of SC-or CSF-pretreated mice.
We then investigated the potential role of Piccolo in the rewarding effects by the CPP, a classical conditioning paradigm in which animals learn to prefer an environment associated with drug exposure. The mice were infused with AS, SC or CSF for 3 days before the training of CPP (Figure 2d ). As shown in Figure 2e , the CSF-treated mice showed baseline preference for either side of the test chambers prior to METH administration, and developed the significant place conditioning after training with METH (F (5,42) = 9.12; P < 0.05). Notably, the Piccolo AS-pretreated mice showed approximately a double degree of place conditioning compared to those treated with SC or CSF, indicating that the AS-treated mice developed an enhancement of rewarding effect to METH. The mice were killed immediately after the behavioral test to measure Piccolo protein levels in NAc. Piccolo expression in NAc responding to METH was dramatically increased, whereas AS effectively decreased its expression (Figure 2f ). These results indicate that Piccolo downregulation was sufficient to confer METH-enhanced sensitization and rewarding effect, which is mediated predominantly by the dopaminergic system. No evidence of neurotoxicity in pathological histology was found outside of the mechanical disruption produced by implantation of the infusion cannula in our experimental conditions (data not shown).
We finally measured DA release in the NAc by a microdialysis technique. The mice were infused with Piccolo AS, SC or CSF for 3 days before daily METH administration (1 mg kg À1 , s.c.) for 3 days (Figure 2g ). The basal levels of DA in NAc did not differ among CSF-, AS-or SC-treated mice (CSF, 0.58±0.21 nM; AS, 0.49 ± 0.17 nM; SC, 0.60 ± 0.18 nM) before the final challenge of METH. As expected, DA levels in the NAc were markedly increased immediately after the final challenge of METH. Obviously, AS pretreatment promoted METH-induced DA release in the NAc compared with SC or CSF (F (2,9) = 5.874; P < 0.05; Figure 2h ). These data strongly supported Piccolo regulates DAT internalization X Cen et al the findings in behavioral tests, suggesting that the enhanced accumulation of DA in NAc resulted from AS may contribute to the amplified responsiveness to METH; moreover, Piccolo may play a role in modulating synaptic DA concentration. Taken these results together, Piccolo overexpression in NAc may present a mechanism of opposing the behavioral responsiveness to METH.
Piccolo is colocalized in dopaminergic neurons
To study whether Piccolo is expressed in dopaminergic neurons, double immunostaining was performed in primary cultured dopaminergic neurons. The immunoreactivities of Piccolo and TH revealed an extensive overlap along neuronal projections, indicating that Piccolo is present at dopaminergic synapse ( Figure 3a) . Notably, abundant Piccolo immunoreactivity was observed as clusters and puncta at the dopaminergic terminals (Figure 3b ). Moreover, we also found that almost all of the DATimmunopositive clusters were present at Piccolocontaining clusters situated along dendritic profiles (Figure 3c ), implying the potential interplay of these two molecules. These results strongly support the conclusion that Piccolo is a shared component of the dopaminergic synapses. Piccolo C 2 A domain attenuates the inhibition of DA uptake induced by METH through modulating plasmalemmal DAT expression Total DAT expression levels showed no changes when hDAT-PC12 cells were exposed to either METH (1 mM) for various time periods or concentrations for 30 min (Figures 4a and b) . However, the level of cell surface hDAT was reduced in time-dependent manner, and importantly, such reduction was paralleled with the extent of the inhibition of [ (3, 20) = 18.68, P < 0.01), indicating that the C 2 A domain expression could attenuate METH-induced inhibition of DA uptake (Figure 4f, right panel) .
Because an increase in DA uptake could be resulted from more DAT molecules expressed at the cell surface, we introduced these vectors into hDAT-PC12 cells, and analyzed plasmalemmal hDAT expression by cell-surface biotinylation. The expression levels of cell-surface hDAT did not increase significantly after transfection of C 2 A domain, PDZ domain or p13192 in basal conditions (Figure 4g ). When the cells were pretreated with 1 mM METH for 30 min, C 2 A domain transfection significantly attenuated the decrease in cell surface hDAT level compared to pCMV (F (3, 8) = 14.61, P < 0.01), whereas PDZ domain and p13192 showed no effects (Figure 4h ). Such change was consistent with that of [ Piccolo C 2 A domain modulates DAT internalization by a mechanism of membrane association Given that DAT can be internalized and/or recycled, we speculated that the decreased lose of membrane DAT induced by METH in C 2 A domain-transfected cells could be resulted from attenuated DAT internalization. To test this hypothesis, DAT internalization was measured by reversible biotinylation in hDAT-PC12 cells. We found that C 2 A domain expression could not affect the basal DAT internalization, as revealed by the similar amount of internalized DAT among all groups (Figure 5a ). However, DAT internalization was significantly attenuated by C 2 A domain expression when the cells were exposed to 1 mM METH for 30 min (F (3, 8) = 8.55, P < 0.01; Figure  5b ). Expression of both PDZ domain and p13192 failed to affect the basal or METH-induced DAT internalization. Double immunostaining for hDAT and c-Myc-tagged C 2 A domain showed the similar findings that the cells transfected with C 2 A domain still maintained a strong plasmalemmal hDAT immunoreactivity responding to METH, whereas a relatively large amount of internalized hDAT was observed in cytosolic compartments of the cells transfected with empty pCMV (Figure 5c ). These results indicated that Piccolo C 2 A domain attenuates METH-induced DAT internalization, which accounts for the decrease in the loss of DAT at cell surface. 
Piccolo regulates DAT internalization X Cen et al
To study the potential mechanism underlying the action of Piccolo C 2 A domain on DAT internalization, we introduced C 2 A domain into hDAT-PC12 cells and then analyzed membrane subcellular distributions of Piccolo, C 2 A domain, hDAT as well as PIP 2 . The cells were homogenized in regular RIPA buffer containing 1% Triton-X 100, and separated into a soluble supernatant and a particulate membrane fraction (120 000 g, 60-min pellet). The latter was solubilized again in RIPA buffer or RIPA buffer containing 0.1 M Na 2 CO 3 (pH 11.5), which can extract a major part of detergentresistant Piccolo protein from brain tissues. 12 As shown in Figure 5d , Piccolo, Piccolo C 2 A domain and PIP 2 did not fractionate like a soluble cytosolic protein but was mainly found in membrane sediment extracted by Na 2 CO 3 , indicating that a substantial (g, h) Piccolo C 2 A domain could not influence DAT surface expression in hDAT-PC12 cells responding to saline (g). However, it attenuated METH-induced loss of surface DAT (h). **P < 0.01, compared with pCMV in METH-treated group.
fraction of membrane-bound Piccolo, C 2 A domain and PIP 2 are associated with the same plasmalemmal rafts. Interestingly, a significant amount of hDAT was also recovered in both soluble fraction and membrane sediment extracted by Na 2 CO 3 , indicating that a relatively major part of membrane DAT is localized at the same subcellular fraction with Piccolo C 2 A domain and PIP 2 . The similar distributions of these components in lipid raft fractions hint that C 2 A domain-PIP 2 interaction may be involved in the distribution of plasmalemmal DAT. In contrast, syntaxin 1A and synaptophysin, the integral membrane proteins, were almost completely recovered in soluble cytosolic fraction, but not in a detergentresistant fraction. Rim 2, a scaffolding protein with C 2 domain, is known to interact with Piccolo and to regulate presynaptic events. However, its similar subdistribution in the three fractions was different from that of Piccolo C 2 A domain. To get an insight into the interplay among DAT, Piccolo C 2 A domain and PIP 2 , double immunostaining was performed. We found that Piccolo C 2 A domain mainly anchored nonuniformly to the inner leaflet of plasma membrane (Figure 5e ), which is consistent with its property of targeting membrane PIP 2 . Notably, the distribution pattern of C 2 A domain resembled that of hDAT, as revealed by the paralleled immunoreactivities at membrane microdomains (Figure 5f ).
Internalization of plasmalemmal DAT is PIP 2 -dependent
The concept of PIP 2 as a spatially localized regulator of membrane trafficking is clearly illustrated by its key role in clathrin-mediated endocytosis for transporter. If plasmalemmal DAT is triggered to internalize by METH, it should be accompanied by PIP 2 for recruiting endocytic adaptors through PIP 2 -binding modules. To test this idea, hDAT and PIP 2 were double-stained in hDAT-PC12 cells after treatment of saline or 1 mM METH for 30 min. Surprisingly, the internalized DAT triggered by METH was found to colocalize with the PIP 2 in the cytosolic compartment ( Figure 6, bottom panel) , whereas the saline-treated cells only showed the constitutively internalized PIP 2 and DAT ( Figure 6, top panel) . These results further demonstrated that DAT internalization is also a clathrin-dependent process requiring the assembly of endocytic components like PIP 2 .
Interaction of Piccolo C 2 A domain and PIP 2 Although Piccolo C 2 A domain binding to PIP 2 has been demonstrated using artificial membranes, 15 there is no evidence indicating interaction of the two molecules in living models. We first investigated whether plasmalemmal clusters of Piccolo immunoreactivity coincide with sites of local PIP 2 accumulation using double immunostaining. The clusters of Piccolo immunoreactivities in dendrite profile colocalized precisely with those of PIP 2 in the primary cultured dopaminergic neurons (Figure 7a) . Moreover, the localization of transfected C 2 A domain in hDAT-PC12 cells was similar with that of PIP 2 , which revealed a patchy staining pattern at plasma membrane (Figure 7b) . Importantly, the clusters with strong immunoreactivity of C 2 A domain also showed substantially larger and stronger labeling macroscopic of PIP 2 clusters, indicating that C 2 A domain may sequester PIP 2 , thus augmenting the formation of microscopically detectable plasmalemmal PIP 2 clusters.
To better understand the interaction of the two molecules, we generated a PIs binding model of Piccolo C 2 A domain with Ca 2 þ docking. As show in Figure 7c , the three-dimensional structure indicated that the predicted PIs binding sites are Ca 2 þ -binding loops at the top of C 2 A domain, which shows the similar binding residues for phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PIP) and PIP 2 . Notably, the crystal packing contacts for PIP 2 were the clusters of basic/aromatic residues including 4668-4670 (DNN), 4697-4698 (QK), 4738-4743 (DYDRFS) and 4746 (D). The potential importance of these residues is highlighted by the fact that they are completely conserved among rat, mouse, human and chicken Piccolo. 22 Calculation of the electrostatic surface potential of C 2 A domain showed that PIP 2 binding sites are positively charged (Figure 7d ), further indicating that clustering PIs by C 2 A domain depends on electrostatic interactions between the positively charged residues in proteins and the negatively charged headgroups of PIs. The lowest binding energies of Piccolo C 2 A domain for PI, PIP and PIP 2 with Ca 2 þ docking were À59.491, À93.229 and À102.642 Kcal, respectively, suggesting a specific interaction between PIP 2 and C 2 A domain. Furthermore, the space-filling model showed that PIP 2 is tightly packed against the top surface of C 2 A domain, which forms a favorable pocket to accommodate the moiety of PIP 2 (Figure 7e ).
Piccolo regulated DAT function not through syntaxin 1A
As syntaxin 1A has been demonstrated to regulate the expressions and activities of serotonin transporter (SERT) and g-aminobutyric acid (GABA) transporters, 23, 24 Piccolo might regulate DAT surface expression through interaction with syntaxin 1A. We first investigated whether syntaxin 1A could bind to Piccolo, though syntaxin is identified to bind to Piccolo. 25 The lysates from hDAT-PC12 cells were immunoprecipitated with anti-syntaxin 1A, followed by hDAT immunoblotting. As shown in Supplementary Figure 1a , hDAT were present in the lysate. As expected, we also detected co-immunoprecipitation of hDAT and syntaxin 1A in following immunoprecipitation with anti-hDAT (Supplementary Figure 1b) . These results showed an apparent association of these two molecules, which was supported by previous reports. 26 We then investigated whether syntaxin 1A could regulate DAT activity. The hDAT-PC12 cells were pretreated with Bont/C1, a toxin that specifically cleaves syntaxin 1A, followed by Taken together, these data suggest that DAT and syntaxin 1A may mechanically, but not functionally, interact. Given the incapability of syntaxin 1A itself in modulating DAT, it unlikely mediates the role of Piccolo in regulating DAT expression at plasma membrane.
Discussion
The contribution of dopaminergic transmission to behavioral sensitization has been well recognized. Expression of certain proteins appears to be compensatory adaptation to the excessive DA signaling, which could be biologically adaptive mechanisms contributing to addiction. Nevertheless, some proteins likely function in a reverse manner. For example, we have previously found that the expression of tissue plasminogen activator plays a positive role in morphine-induced synaptic plasticity, 19 whereas tumor necrosis factor-a expression in NAc inhibits METH-induced dependence. 18 Piccolo expression was upregulated by repeated METH administration and partial knockdown of Piccolo expression by antisense technique led to elevated synaptic DA concentration in the NAc and two major behavioral manifestations in mice: heightened hyperlocomotor activity and rewarding effect. These findings strongly show that Piccolo overexpression elicited by METH may serve as a homeostatic mechanism that prevents behavioral sensitization by maintaining the expression and activity of the plasmalemmal DAT.
The human Piccolo gene contains more than 25 exons spanning over 350 kb of genomic DNA maps to 7q11.23-q21.3, a region of chromosome 7 implicated as a linkage site for autism and Williams Syndrome. 22 Therefore, dysfunction of Piccolo may be involved in cognitive impairment and mental retardation. 27 The mechanism underlying Piccolo upregulation caused by METH remains to be elucidated. Nevertheless, inhibitory feedback to the excessive DA signaling would be a plausible candidate.
Piccolo has been reported to localize at the GABAergic and glycinergic presynaptic terminal, 10 and our findings in immunostaining demonstrated that it is also expressed at dopaminergic presynaptic terminal. DAT can be internalized from the plasma membrane at a relatively rapid rate, which provides a mechanism by which the turnover rate and density of the plasmalemmal DAT can be quickly and finely modulated. 6, 8 Signaling molecules, glycosylation and DAT substrates have been shown to regulate DAT membrane trafficking. Given those findings in vivo behaviors tests and the properties of Piccolo, we assumed that Piccolo may play a role in modulating DA flux and DAT distribution at dopaminergic terminals. To address this issue, we investigated DA uptake and membrane DAT expression in hDAT-PC12 cells expressing different functional domain of Piccolo. METH caused DA uptake inhibition in parallel with decreased DAT surface expression, which was well consistent with those works defining the dynamically internalized DAT in hDAT-PC12 cells triggered by amphetamine. These results further support the notion that redistribution of surface DAT caused by METH-like drugs may present an important mechanism underlying the consequently reduced DAT activity. Our data showed that Piccolo C 2 A, but not PDZ domain, attenuated METH-induced DA uptake inhibition by retaining DAT expression at cell surface. Because DAT can be internalized and/or recycled, we speculated that the decreased loss of membrane DAT could be resulted from attenuated DAT internalization. Such hypothesis was demonstrated by reversible biotinylation, which revealed the decreased DAT internalization in C 2 A domain-transfected cells responding to METH.
It is well established that PIP 2 functions in regulating cytoskeleton, channels and transporters, and membrane trafficking at presynaptic terminal. 16, 28, 29 Especially, PIP 2 is essential at several stages of endocytosis for the sequential recruitment of adaptor and accessory proteins to endocytic sites. 30, 31 METH rapidly causes both DAT internalization and conformational rearrangement to an intracellularly oriented transporter from which DA is released. Such process is proposed to be a drastic membrane movement and requires PIP 2 to assemble various molecules to form endocytic compartment. Significantly, we found that PIP 2 exhibits a similar distribution pattern with DAT at membrane microdomains. Furthermore, internalized DTA triggered by METH is accompanied with PIP 2 in endocytic compartments. These results indicate that PIP 2 is an important regulator in the process of DAT internalization.
A couple of scaffolding proteins such as GAP43, CAP23 and Dap160 have shown their ability to sequester membrane PIP 2 , thus potentially modulating the endocytic process. 32, 33 In this study we obtained several evidences further supporting the notion that Piccolo can electrostatically sequester PIP 2 . Firstly, Piccolo C 2 A domain may laterally bind membrane PIP 2 , and augment PIP 2 clusters in hDAT-PC12 cells. In principle, the augmented clusters could represent the sequestration of phospholipids like PIP 2 at the plasma membrane. 34 Secondly, the crystal packing contacts for PIP 2 were the clusters of basic/ aromatic residues, which exhibit a universal capability of sequestering membrane PIP 2 . 35 Thirdly, the space-filling model showed that Piccolo C 2 A domain may pocket PIP 2 by a cupped shape of polybasic region, where the local positive potential electrostatically attracts the negatively charged PIP 2 . Finally, C 2 A domain shows stronger interacting potential with PIP 2 than PI or PIP. Our results are consistent with previous investigations indicating that PIs binding with Piccolo C 2 A domain is largely driven by electrostatic interaction. 15 Based on these findings, we speculated that Piccolo C 2 A domain may regulate METH-triggered DAT internalization through sequestering PIP 2 , and the findings in immunostaining strongly support this prediction. Piccolo C 2 A domain mainly anchors nonuniformly to the inner leaflet, which is accompanied with the retention of DAT and PIP 2 at membrane microdomains; moreover, it clearly attenuated METH-triggered DAT and PIP 2 internalization in cytosol. These results show that Piccolo may sequester or 'control' locally PIP 2 by C 2 A domain in membrane raft and suppress PIP 2 -dependent endocytic process, thus leading to the attenuated DAT internalization.
How does the Piccolo C 2 A domain-PIP 2 interaction fulfill a function in modulating DAT internalization and psychostimulant responsiveness? An explanation could be that the endocytic process for DAT internalization is inhibited directly through PIP 2 sequestration. Given the strong dependence of the endocytic machinery on PIP 2 , more membrane PIP 2 is considerably mobilized for the accelerated DAT internalization triggered by METH. This situation would place the endocytic machinery of dopaminergic presynaptic terminal in a compromised position of insufficient availability of PIP 2 , and thus slowing down the DAT internalization. Similarly, a dominant-negative mutant of dynamin I, a component of endocytic machinery, inhibits both PKC-and amphetamine-dependent DAT internalization; 7, 36 interruption of adaptor proteins present in clathrin-coated pits like epsin interferes with DAT endocytosis. 37 Another explanation could be that Piccolo C 2 A domain may retain DAT at cell surface by promoting membrane stability. METH causes both DAT internalization and conformational rearrangement to an intracellularly oriented transporter from which DA is released. In this process PIP 2 acts as a positive regulator in modulating actin filament assembly and membrane movement by creating membrane microdomains and binding proteins with lipid-specific interaction. 38, 39 Therefore, overexpressed Piccolo elicited by METH may enhance the association with membrane PIP 2 or other PIs through C 2 A domain and disturb PIP 2 -dependent actin assembly, thereby strengthening membrane stability and weakening DAT internalization. In this case, Piccolo may function as a general stabilizer for plasma membrane and DAT. It is worth noting that protein interacting with C kinase 1 (PICK1), a skeletal component, may also stabilize and maintain DAT at plasma membrane. 40 Piccolo likely binds to syntaxin 1A through its C 2 A domain, because synaptotagmin C 2 A domain which shares a great structural similarity with Piccolo C 2 A domain interacts with syntaxin 1A. 15, 40 Syntaxin 1A directly regulates the expressions and activities of SERT and GABA transporter. 23, 24 Interestingly, a recent work has identified that syntaxin 1A also binds to DAT. 26 However, Piccolo C 2 A domain appears not to regulate METH-induced DAT internalization through syntaxin 1A, because DA uptake is not affected when syntaxin 1A is inhibited.
Our findings reveal that Piccolo is capable of regulating METH-induced DAT internalization, leading to the change of DA signaling and synaptic strength. The precise mechanism underlying the role of C 2 A domain-PIP 2 interplay in DAT internalization remains to be determined. No matter which mechanism could be more reasonable, sequestration of PIP 2 in lateral domains through C 2 A domain appears to be important for Piccolo to regulate DAT internalization. Therefore, a greater understanding of the molecular regulators for PIP 2 , which governs DAT trafficking, would shed light on the modulation of DAT surface presentation. Further investigation measuring membrane fluorescence resonance energy transfer and PIP 2 turnover/mobilization will help interpret the contribution of the proposed mechanisms.
The present investigation illustrates a paradigm that Piccolo, a presynaptic scaffolding protein, targets membrane PIP 2 by its C 2 A domain, contributing to the regulation of DAT internalization. Piccolo upregulation may represent a homeostatic response of dopaminergic neurons in the NAc to excessive dopaminergic transmission, dampening hypersensitivity and rewarding effect.
